My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Capricor Therapeutics, Inc. - Common Stock (NQ:CAPR)

5.770 -0.100 (-1.70%)

Streaming Delayed Price Updated: 3:59 PM EST, Nov 13, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Capricor Therapeutics, Inc. - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

10 Health Care Stocks With Whale Alerts In Today's Session ↗

October 16, 2024

Via Benzinga

$1000 Invested In This Stock 5 Years Ago Would Be Worth $6,800 Today ↗

October 11, 2024

Via Benzinga

Capricor Therapeutics Says Duchenne Muscular Dystrophy Candidate Shows Sustained Cardiac, Skeletal Benefits After 3 Years ↗

October 11, 2024

Capricor Therapeutics announced promising 3-year results from its HOPE-2 extension study for deramiocel in treating Duchenne muscular dystrophy, showing significant cardiac and motor function...

Via Benzinga

Fastenal Posts Upbeat Earnings, Joins Wells Fargo, JPMorgan And Other Big Stocks Moving Higher On Friday ↗

October 11, 2024

Via Benzinga

Forecasting The Future: 9 Analyst Projections For Capricor Therapeutics ↗

October 09, 2024

Via Benzinga

Here's How Much $100 Invested In Capricor Therapeutics 5 Years Ago Would Be Worth Today ↗

September 30, 2024

Via Benzinga

Deep Dive Into Capricor Therapeutics Stock: Analyst Perspectives (5 Ratings) ↗

September 20, 2024

Via Benzinga

Unveiling 6 Analyst Insights On Capricor Therapeutics ↗

July 02, 2024

Via Benzinga

PepsiCo, DocuSign, Robinhood And Other Big Stocks Moving Higher On Tuesday ↗

October 08, 2024

Via Benzinga

MarketBeat Week in Review – 9/30 - 10/4

October 05, 2024

A strong jobs report and a temporary settlement of the port strike lifted stocks but inflation and earnings data could set investors up for more volatility

Via MarketBeat

Topics Economy

12 Health Care Stocks Moving In Friday's Intraday Session ↗

October 04, 2024

Via Benzinga

Apogee Enterprises Posts Upbeat Earnings, Joins Frontier Group, JetBlue Airways And Other Big Stocks Moving Higher On Friday ↗

October 04, 2024

Via Benzinga

What's Going On With Capricor Therapeutics Stock Friday? ↗

June 28, 2024

The biotechnology company said deramiocel increased cardiac function based on several different measures.

Via Benzinga

Expert Ratings For Capricor Therapeutics ↗

May 14, 2024

Via Benzinga

Nike Reports Weak Sales, Joins Lamb Weston And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

October 02, 2024

Via Benzinga

IGM Biosciences, CPI Card And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

October 01, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

September 30, 2024

Via Benzinga

Prime Medicine, MINISO Group, Li Auto, Weibo And Other Big Stocks Moving Higher On Monday ↗

September 30, 2024

Via Benzinga

Capricor Therapeutics Is Up Over 100%, Could Rise Even Higher

September 30, 2024

Capricor Therapeutics Inc. (NASDAQ: CAPR) is a biotechnology firm focused on developing cell and exosome-based treatments for rare diseases like iomyopathy

Via MarketBeat

Dow Tumbles Over 200 Points; CERo Therapeutics Shares Jump ↗

September 25, 2024

Via Benzinga

Topics Stocks

Crude Oil Down Over 1%; Stitch Fix Shares Plummet ↗

September 25, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

September 25, 2024

Via Benzinga

Hewlett Packard Enterprise, Nvidia, Progress Software And Other Big Stocks Moving Higher On Wednesday ↗

September 25, 2024

Via Benzinga

Nvidia, Alibaba, Capricor Therapeutics, TSMC, Tesla: Why These 5 Stocks Are On Investors' Radars Today ↗

September 24, 2024

On Tuesday, major U.S. indices closed higher, with the Dow Jones Industrial Average gaining 0.2% to reach 42,208.22.

Via Benzinga

Topics Stocks

Why Capricor Therapeutics Stock Is Soaring Tuesday ↗

September 24, 2024

Capricor Therapeutics Inc (NASDAQ:CAPR) shares are trading higher Tuesday after the company announced intent to file a biologics license application (BLA) for the full approval of Deramiocel for the...

Via Benzinga

Week In Review: Nippon Shinyaku Signs $735 Million Deal For DMD Therapy ↗

September 21, 2024

Japan’s Nippon Shinyaku will acquire European rights for a Duchenne muscular dystrophy disease therapy developed by Capricor Therapeutics of San Diego. Nippon Shinyaku will pay $20 million upfront and...

Via Talk Markets

EXCLUSIVE: Capricor Therapeutics Inks European Expansion, Commercialization Pact For Lead Asset With Japanese Pharma Firm ↗

September 17, 2024

Capricor Therapeutics partners with Nippon Shinyaku for the European commercialization of Duchenne muscular dystrophy treatment, deramiocel, with a potential $1.5 billion in milestone payments from...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

June 11, 2024

Via Benzinga

What's Going On With Capricor Therapeutics Stock Tuesday? ↗

June 11, 2024

Capricor Therapeutics announced successful completion of a Type-B meeting with the U.S. Food and Drug Administration (FDA).

Via Benzinga

What's Going On With Capricor Therapeutics Stock Tuesday? ↗

June 04, 2024

Capricor Therapeutics, Inc. (NASDAQ: CAPR) is trading higher Tuesday after the company announced three-year results from the ongoing HOPE-2 open-label extension

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.